Member Info for Borsaci06

Pre-Market Time (ET) 05:56:42
Pre-Market Share Volume 65
Pre-Market Price $3.85

got it now
adjustment after financing
)::(

are they buying more or selling more.
I am confused

Which one to be trusted ?

** holding on Redx pharma website
RM Special Holdings 3 LLP
175,846,786
90.06%
( Last updated 22/07/2020 )
https://www.redxpharma.com/investors/aim-rule-26/

** holding on TR-1 RNS Number : 5457R 30 June 2020
Redmile Group, LLC
174,837,998
92.03
crossed or reached on 15/06/2020
notified on 29/06/2020
https://www.londonstockexchange.com/news-article/REDX/holding-s-in-company/14597187

time has come.
we`ll find out what these warrant holders are made of ?

Rose Above Upper Bollinger Band
https://lse.swingtradebot.com/alerts/23-rose-above-upper-bollinger-band

the way it`s been
may reach 360p
before results

" If all of the warrants mentioned above were exercised for cash in full, the proceeds would be approximately $7.9 million "

is that why US was falling last 2 days

seen this one
Aug 18 2020, 14:25 235.00 250,000 230.00 234.00 Buy £587,500.00

https://clinicaltrials.gov/ct2/show/NCT04385095?term=sng001&cond=covid+19&draw=2&rank=1

Estimated Primary Completion Date : August 31, 2020

Hospital results took around 15 weeks 6 days
so I am assuming after 14 September 2020
home results would be released

in my humble opinion

hold4results
recruitment for the hospital part was updated with complition
recruitment for the home part is yet to be updated

wonder how many sticks lands on me
this is my estimated result day

31 March 2020 commencement of dosing in hospital
20 July 2020 Positive results

26 May 2020 Initiation of in home setting
??? Ressults

Hospital results took around 15 weeks 6 days
so I am assuming around 14 September 2020
home results would be released

in my humble opinion

what is he on about ?

@BertrandBio
$FARN spin re HIBISCUS trial for Traumakine/IFN-Bate-1a IV: "No corticosteroid use will be accepted in the study which is expected to enroll patients over 6-8 mo throughout the US with many significant hospitals participating" (because they believe they showed CS annealed IFN-B1a effect in ARDS failed ph3)

Today's PR: "The study will test Traumakine against
both placebo and dexamethasone, which is now a part of the standard of care in the US."
=> 0 rationale for this trial, but let's dose anyways.

https://twitter.com/BertrandBio/status/1295644684837179392

you never know
your wish may come tomorrow morning with leg up
if US keeps buying over night

that article not much liked by US
if you rely on US not the company/tech

then there is not much to say here
each to their own

mtph has not updated the market whether or not they have enough supply/stock of Panobinostat for " clinical development program of MTX110, our product for DIPG and potentially other pediatric brain cancers.... "

assuming they have enough for clinical development program of MTX110.
then what happens
if the dispute is not resolved / goes against the company ?
need more from company which steps taken....

Bullish Swing Setup

https://lse.swingtradebot.com/equities/MTPH:LSE